Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma

JCO Precis Oncol. 2019 Sep 20:3:PO.19.00028. doi: 10.1200/PO.19.00028. eCollection 2019.

Authors

Angela Steineck¹, Niklas Krumm², Jay F Sarthy^{1

3}, Colin C Pritchard², Teresa Chapman², Andrew W Stacey², Nicholas A Vitanza^{1

3}, Bonnie Cole^{1

4}

Affiliations

¹ Seattle Children's Hospital, Seattle, WA.
² University of Washington, Seattle, WA.
³ Fred Hutchinson Cancer Research Center, Seattle, WA.
⁴ University of Washington School of Medicine, Seattle, WA.

No abstract available

Grants and funding

T32 CA009351/CA/NCI NIH HHS/United States